ARTICLE | Distillery Therapeutics
Endocrine/metabolic
May 3, 2018 4:18 PM UTC
Mouse studies suggest KHK inhibitors could help treat hereditary fructose intolerance. In a mouse model of hereditary fructose intolerance, systemic KHK knockout decreased hypoglycemia, fibrosis and inflammation in the liver compared with normal KHK expression, and a tool compound KHK inhibitor decreased hypoglycemia compared with vehicle. Next steps could include testing other KHK inhibitors in the model...
BCIQ Company Profiles
BCIQ Target Profiles